Investigational drug reduces high potassium levels in chronic kidney disease patients

(University of Maryland Medical Center) Research published today found that the investigational drug patiromer decreased high potassium levels and maintained normal potassium levels in patients with chronic kidney disease. The results of a multicenter trial appear in the New England Journal of Medicine.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news